Skip to Content

Tribenzor FDA Approval History

FDA Approved: Yes (First approved July 23, 2010)
Brand name: Tribenzor
Generic name: amlodipine, hydrochlorothiazide and olmesartan
Dosage form: Tablets
Company: Daiichi Sankyo
Treatment for: High Blood Pressure

Tribenzor (amlodipine, hydrochlorothiazide and olmesartan) is a three-in-one combination product taken once-daily for the treatment of hypertension.

Development Timeline for Tribenzor

DateArticle
Jul 26, 2010Approval FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.